Protein–radical–oxidation targeting enediyne chimera reduces viral activity in coronaviruses, suggesting a new antiviral strategy.
Conventional targeted protein degradation (TPD) strategies operate by hijacking intracellular proteolytic machinery, limiting their therapeutic scope. Here, we present protein–radical–oxidation targeting enediyne chimera (PROTEC), a TPD platform that can be...
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: